
Bent Ejlertsen
Copenhagen, Denmark
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 261 publications
AI-assisted image analysis of tumor-infiltrating lymphocytes as a prognostic marker in chemotherapy-naïve luminal breast cancer.
Journal: NPJ breast cancer
Published: October 24, 2025
17β-Hydroxysteroid dehydrogenases 1 and 2: potential markers for breast cancer recurrence and tamoxifen resistance among premenopausal women diagnosed with breast cancer in Denmark.
Journal: Breast cancer research : BCR
Published: September 11, 2025
Author Correction: Functional mechanisms underlying pleiotropic risk alleles at the 19p13.1 breast-ovarian cancer susceptibility locus.
Journal: Nature communications
Published: September 09, 2025
Statin use and risk of contralateral breast cancer: an updated cohort study with landmark analysis.
Journal: European journal of epidemiology
Published: August 11, 2025
Validation of a deep learning-based AI model for breast cancer risk stratification in postmenopausal ER+/HER2-breast cancer patients.
Journal: Breast (Edinburgh, Scotland)
Published: July 22, 2025
Enhancing HER2-low breast cancer detection with quantitative transcriptomics.
Journal: NPJ breast cancer
Published: May 20, 2025
Timely germline BRCA testing after invasive breast cancer promotes contralateral risk-reducing mastectomy and improves survival: an observational retrospective study.
Journal: Breast cancer research and treatment
Published: February 13, 2025
Comprehensive mapping elucidates high risk genotypes in primary metastatic breast cancer.
Journal: Neoplasia (New York, N.Y.)
Published: January 28, 2025
Genetic variants in tamoxifen metabolism and early treatment discontinuation among premenopausal breast cancer patients.
Journal: Breast cancer research and treatment
Published: January 28, 2025
Multi-transcriptomics predicts clinical outcome in systemically untreated breast cancer patients with extensive follow-up.
Journal: Breast cancer research : BCR
Published: January 22, 2025
Association between low-dose aspirin use and breast cancer recurrence: a Danish nationwide cohort study with up to 23 years of follow-up.
Journal: British journal of cancer
Published: January 16, 2025
Last Updated: 09/26/2026